Professional Marketing briefs

Share this article:
Romark Laboratories received a warning letter from the FDA regarding its product Alinia (nitazoxanide). The FDA charged that the sales aid and oral statements for Alinia are false or misleading because they promote unapproved uses and broaden the indication for Alinia, make unsubstantiated superiority claims, omit and minimize the risks associated with Alinia and/or make misleading compliance claims.

Roche added a new component to its $14 million diabetes education campaign, which pairs healthcare practitioners with Roche staff. “Creative Coaching” helps healthcare professionals with “the art of patient engagement.” Roche manufactures the Accu-Chek line of blood glucose monitors. The professional education program, Behavior Change through Patient Engagement, is multifaceted and includes a website with online tools and information.

San Mateo, CA-based Epocrates unveiled an OTC drug module that will allow clinicians to access the latest information for hundreds of brand name OTC drugs right from their iPhone, BlackBerry, Palm or Windows device. The OTC drug module is already used by more than 625,000 in the US.
Share this article:

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"